search
diabetes
Trends
- 1
A new study suggests that people who discontinue GLP-1 medications, such as Ozempic and Wegovy, may face an increased risk of heart attack and stroke. The findings add to ongoing debate about how long patients should stay on these widely used weight-loss and diabetes drugs, and whether the cardiovascular benefits persist after stopping treatment.
- 2Scientists Find Pancreatic Cells One Genetic Tweak From Treating DiabetesโSome Pancreatic Cells Are Just One Genetic Tweak Away From Treating Diabetes https:// fed.brid.gy/r/https://www.wire d.c
A new Wired report describes research showing some pancreatic cells are only a single genetic modification away from producing insulin, raising hopes for new diabetes treatments. The findings suggest cell reprogramming could one day restore insulin production in patients, and the story is drawing attention as a potential breakthrough in diabetes and regenerative medicine research.
- 3Doctors weigh in on microdosing Ozempic trendโIs microdosing Ozempic safe? An obesity medicine doctor on the trend, the risks, and when a low dose makes sense
An obesity medicine doctor is addressing the growing trend of taking small, lower-than-prescribed doses of Ozempic, the weight-loss and diabetes drug semaglutide. The expert explains the potential risks of adjusting doses without medical guidance, including reduced effectiveness and side effects, while noting the limited circumstances where a low dose may genuinely make sense for some patients.
- 4India proposes junk food ban in and near schoolsโIndia tightens school junk food rules amid obesity rise India proposes banning junk food sales in school canteens and wi
India has proposed banning junk food sales in school canteens and within 50 meters of school premises, in an effort to curb rising obesity and diabetes rates among children. The move signals a tougher regulatory stance on food sold around educational institutions and has drawn attention to children's health concerns in the country.
- 5Doctors warn GLP-1 drug users face heat wave health risksโAmid heat wave, doctors warn of health risks for people taking GLP-1 drugs
Doctors are warning that people taking GLP-1 weight-loss and diabetes drugs such as Ozempic may face heightened health risks during the current heat wave. Concerns center on dehydration, as the medications can suppress thirst and appetite, potentially leaving users vulnerable to heat exhaustion and related complications. Patients are being advised to drink water regularly and take precautions in high temperatures as extreme heat persists across many regions.
- 6Heart and Kidney Problems Rise Over Time in Type 2 DiabetesโผHeart and Kidney Problems in Type 2 Diabetes Patients Increase with Time
New coverage reports that heart and kidney complications in patients with type 2 diabetes increase as the disease progresses over time. The finding underscores the cumulative toll of diabetes on cardiovascular and renal health and highlights the importance of long-term monitoring and management of blood sugar, blood pressure and kidney function in affected patients.
- 7GLP-1 drugs, mental health and exercise in menopause examinedโผGLP-1's and mental health; exercise and menopause
Public health coverage is drawing together two related topics: the possible mental health effects of GLP-1 weight-loss and diabetes drugs, and the role of exercise for women going through menopause. Listeners are weighing reported mood changes linked to GLP-1 medications against growing evidence that physical activity can ease menopause symptoms such as hot flashes, sleep problems and weight gain.